A Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3
1 other identifier
interventional
5,663
1 country
1
Brief Summary
Our project will assess the feasibility and estimate preliminary efficacy of a multilevel intervention to improve HPV vaccine series initiation among adolescents in Medicaid and CHIP. The investigators will use two intervention components: postcards and an iPad survey system. To estimate efficacy the investigators will select potential participants from Florida Medicaid and CHIP. The investigators will assess their claims for the HPV vaccine before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2015
CompletedFirst Submitted
Initial submission to the registry
December 19, 2019
CompletedFirst Posted
Study publicly available on registry
December 23, 2019
CompletedMay 19, 2020
May 1, 2020
8 months
December 19, 2019
May 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The number of participants receiving HPV vaccine
The percent age eligible participants who initiate HPV vaccination.
Up to 5 months
Number of preventive care visits
The percent age eligible participants received a preventive care visit
Up to 3 months
Study Arms (4)
Postcard campaign
ACTIVE COMPARATORProvider-only intervention
ACTIVE COMPARATORPatient and provider intervention
ACTIVE COMPARATORStandard care
NO INTERVENTIONInterventions
Post card sent to parent only
Accessed by adolescent and provider only
Eligibility Criteria
You may qualify if:
- Enrolled in Florida Medicaid
- Not initiated the HPV vaccine series at the start of the study period.
You may not qualify if:
- Anyone who has a severe (life threatening) allergy to any component of HPV vaccine, esp yeast
- Pregnant
- Not enrolled in Florida Medicaid
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32610, United States
Related Publications (1)
Staras SAS, Vadaparampil ST, Thompson LA, Scherr C, Gurka MJ, Filipp SL, Shenkman EA. Postcard reminders for HPV vaccination mainly primed parents for providers' recommendations. Prev Med Rep. 2020 Aug 26;20:101188. doi: 10.1016/j.pmedr.2020.101188. eCollection 2020 Dec.
PMID: 32953426DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie Staras, PhD
University of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2019
First Posted
December 23, 2019
Study Start
August 1, 2013
Primary Completion
April 1, 2014
Study Completion
March 30, 2015
Last Updated
May 19, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share